FDA 483 - Hospira Australia Pty Ltd. - September 02, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Hospira Australia Pty Ltd, a sterile drug manufacturer in Mulgrave, Victoria, was cited for three observations during an FDA inspection. The firm failed to thoroughly investigate manufacturing discrepancies, did not consistently follow written procedures for equipment cleaning and maintenance, and exhibited inadequate aseptic processing techniques and sanitization practices in cleanroom environments. These issues indicate significant deficiencies in quality control and adherence to established procedures for sterile drug production.
ID · f2b81c3c-db02-4012-aef3-1534dff7c22d